Quince Therapeutics shares surge 24.54% intraday after paying off major European bank debt and advancing restructuring plans.

Quince Therapeutics surged 24.54% intraday, as the company paid off approximately $16.4 million in debt from European Investment Bank with $5.5 million in cash on March 27, relieving a major financial burden. On March 30, the company announced the completion of the debt repayment, allowing it to move forward with restructuring and evaluate strategic alternatives, including mergers, reverse mergers, and asset sales, aimed at maximizing shareholder value.